# Fees-Exceed-the-Costs Waivers Under the Prescription Drug User Fee Act - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/fees-exceed-the-costs-waivers-under-the-prescription-drug-user-fee-act/635ddfab-1882-4949-ab8a-cbc7e467ad7f

> FDA guidance document: Fees-Exceed-the-Costs Waivers Under the Prescription Drug User Fee Act. Issue date: June 01, 1999. Get complete insights and analysis.

---

## Details

- Title: Fees-Exceed-the-Costs Waivers Under the Prescription Drug User Fee Act
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 1999-06-01
- Last Changed: 2019-03-15

## Related Documents

- [Indexing Structured Product Labeling](https://www.globalkeysolutions.net/guidances/guidance-document/indexing-structured-product-labeling/a3bd05e5-ec29-40f1-a24b-27fe16f0c1da)
- [User Fee Waivers for FDC and Co-Packaged HIV Drugs for PEPFAR](https://www.globalkeysolutions.net/guidances/guidance-document/user-fee-waivers-for-fdc-and-co-packaged-hiv-drugs-for-pepfar/13c7af5f-84b1-4023-80d0-9ff6cb3357dc)
- [E9 Statistical Principles for Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/e9-statistical-principles-for-clinical-trials/d427b5ed-dd16-417e-adc2-9f35d3a3df23)